UCH-L1 Inhibitor Alleviates Nerve Damage Caused by Moyamoya Disease

Background. Moyamoya disease (MMD) leads to nerve injury. Exosomes are touted as bio-shuttles for the delivery of distinct biomolecules inside the cells. Recently, UCH-L1 was shown to play a vital role in nerve injury. However, it is still unknown whether UCH-L1 can improve the nerve injury of MMD....

Full description

Saved in:
Bibliographic Details
Main Authors: Minghua Xu, Xiaomin Zhao, Jiang Zhao, Zhisheng Tan, Chengshi Zhang, Yun Huang, Huiping Zhong, Meifeng Guo, Chen Zhang, Ping Ye, Wentao Zheng
Format: Article
Language:English
Published: Wiley 2024-01-01
Series:Applied Bionics and Biomechanics
Online Access:http://dx.doi.org/10.1155/2024/2550642
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832564131914317824
author Minghua Xu
Xiaomin Zhao
Jiang Zhao
Zhisheng Tan
Chengshi Zhang
Yun Huang
Huiping Zhong
Meifeng Guo
Chen Zhang
Ping Ye
Wentao Zheng
author_facet Minghua Xu
Xiaomin Zhao
Jiang Zhao
Zhisheng Tan
Chengshi Zhang
Yun Huang
Huiping Zhong
Meifeng Guo
Chen Zhang
Ping Ye
Wentao Zheng
author_sort Minghua Xu
collection DOAJ
description Background. Moyamoya disease (MMD) leads to nerve injury. Exosomes are touted as bio-shuttles for the delivery of distinct biomolecules inside the cells. Recently, UCH-L1 was shown to play a vital role in nerve injury. However, it is still unknown whether UCH-L1 can improve the nerve injury of MMD. Materials and Methods. Exosomes were isolated from the serum of patients with MMD and healthy controls. The total RNA was extracted from the exosomes, and the level of GFAP and UCH-L1 between the serum exosomes of the two groups was analyzed by a quantitative reverse transcription-polymerase chain reaction and western blot. Exosome labeling and uptake by SH-SY5Y cells were observed by confocal laser microscopy. Cell counting kit-8 assay and flow cytometry were used to determine the viability and apoptosis of SH-SY5Y cells, respectively. Results. Exosomes were successfully isolated and identified from serum. The expression of GFAP and UCH-L1 was significantly higher in the serum-derived exosomes from MMD patients compared with the healthy controls (P <0.05). Compared to the blank and control exosome group, serum-derived exosomes from MMD significantly suppress cellular vitality and promote apoptosis of SH-SY5Y cells, while the use of LDN-91946, a specific inhibitor of UCH-L1, could reverse the effects induced by serum-derived exosomes from MMD. Conclusion. UCH-L1 inhibitor could reverse MMD-induced inhibition of SH-SY5Y cell viability and promotion of apoptosis. UCH-L1 may be a therapeutic target for the treatment of nerve damage caused by MMD.
format Article
id doaj-art-85f9944691484d3a8c8e88ef6a152560
institution Kabale University
issn 1754-2103
language English
publishDate 2024-01-01
publisher Wiley
record_format Article
series Applied Bionics and Biomechanics
spelling doaj-art-85f9944691484d3a8c8e88ef6a1525602025-02-03T01:11:41ZengWileyApplied Bionics and Biomechanics1754-21032024-01-01202410.1155/2024/2550642UCH-L1 Inhibitor Alleviates Nerve Damage Caused by Moyamoya DiseaseMinghua Xu0Xiaomin Zhao1Jiang Zhao2Zhisheng Tan3Chengshi Zhang4Yun Huang5Huiping Zhong6Meifeng Guo7Chen Zhang8Ping Ye9Wentao Zheng10Intensive-Care UnitIntensive-Care UnitDepartment of NeurosurgeryGeriatric DepartmentDepartment of RespiratoryDepartment of Clinical LaboratoryIntensive-Care UnitIntensive-Care UnitIntensive-Care UnitIntensive-Care UnitIntensive-Care UnitBackground. Moyamoya disease (MMD) leads to nerve injury. Exosomes are touted as bio-shuttles for the delivery of distinct biomolecules inside the cells. Recently, UCH-L1 was shown to play a vital role in nerve injury. However, it is still unknown whether UCH-L1 can improve the nerve injury of MMD. Materials and Methods. Exosomes were isolated from the serum of patients with MMD and healthy controls. The total RNA was extracted from the exosomes, and the level of GFAP and UCH-L1 between the serum exosomes of the two groups was analyzed by a quantitative reverse transcription-polymerase chain reaction and western blot. Exosome labeling and uptake by SH-SY5Y cells were observed by confocal laser microscopy. Cell counting kit-8 assay and flow cytometry were used to determine the viability and apoptosis of SH-SY5Y cells, respectively. Results. Exosomes were successfully isolated and identified from serum. The expression of GFAP and UCH-L1 was significantly higher in the serum-derived exosomes from MMD patients compared with the healthy controls (P <0.05). Compared to the blank and control exosome group, serum-derived exosomes from MMD significantly suppress cellular vitality and promote apoptosis of SH-SY5Y cells, while the use of LDN-91946, a specific inhibitor of UCH-L1, could reverse the effects induced by serum-derived exosomes from MMD. Conclusion. UCH-L1 inhibitor could reverse MMD-induced inhibition of SH-SY5Y cell viability and promotion of apoptosis. UCH-L1 may be a therapeutic target for the treatment of nerve damage caused by MMD.http://dx.doi.org/10.1155/2024/2550642
spellingShingle Minghua Xu
Xiaomin Zhao
Jiang Zhao
Zhisheng Tan
Chengshi Zhang
Yun Huang
Huiping Zhong
Meifeng Guo
Chen Zhang
Ping Ye
Wentao Zheng
UCH-L1 Inhibitor Alleviates Nerve Damage Caused by Moyamoya Disease
Applied Bionics and Biomechanics
title UCH-L1 Inhibitor Alleviates Nerve Damage Caused by Moyamoya Disease
title_full UCH-L1 Inhibitor Alleviates Nerve Damage Caused by Moyamoya Disease
title_fullStr UCH-L1 Inhibitor Alleviates Nerve Damage Caused by Moyamoya Disease
title_full_unstemmed UCH-L1 Inhibitor Alleviates Nerve Damage Caused by Moyamoya Disease
title_short UCH-L1 Inhibitor Alleviates Nerve Damage Caused by Moyamoya Disease
title_sort uch l1 inhibitor alleviates nerve damage caused by moyamoya disease
url http://dx.doi.org/10.1155/2024/2550642
work_keys_str_mv AT minghuaxu uchl1inhibitoralleviatesnervedamagecausedbymoyamoyadisease
AT xiaominzhao uchl1inhibitoralleviatesnervedamagecausedbymoyamoyadisease
AT jiangzhao uchl1inhibitoralleviatesnervedamagecausedbymoyamoyadisease
AT zhishengtan uchl1inhibitoralleviatesnervedamagecausedbymoyamoyadisease
AT chengshizhang uchl1inhibitoralleviatesnervedamagecausedbymoyamoyadisease
AT yunhuang uchl1inhibitoralleviatesnervedamagecausedbymoyamoyadisease
AT huipingzhong uchl1inhibitoralleviatesnervedamagecausedbymoyamoyadisease
AT meifengguo uchl1inhibitoralleviatesnervedamagecausedbymoyamoyadisease
AT chenzhang uchl1inhibitoralleviatesnervedamagecausedbymoyamoyadisease
AT pingye uchl1inhibitoralleviatesnervedamagecausedbymoyamoyadisease
AT wentaozheng uchl1inhibitoralleviatesnervedamagecausedbymoyamoyadisease